Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH)

Jessica S. Merlin, Andrew O. Westfall, Mallory O. Johnson, Robert D. Kerns, Matthew J. Bair, Stefan Kertesz, Janet M. Turan, Olivio J. Clay, Joanna L. Starrels, Meredith Kilgore

Research output: Contribution to journalArticle

Abstract

Background: Chronic pain is a common, disabling, and costly comorbidity, particularly in people living with HIV (PLWH). This study developed and pilot tested a pain self-management intervention for chronic pain tailored to PLWH called Skills TO Manage Pain (STOMP). Objectives: Given the additional resources needed to deliver STOMP in HIV clinical settings, an important objective of the pilot study was to assess not only STOMP’s preliminary efficacy, but also its cost-effectiveness. Research design and subjects: The present study draws from a 44-participant, 2-arm randomized pilot trial of the STOMP intervention vs usual care among PLWH and at least moderate chronic pain (Clinicaltrials.gov: NCT02824562). Cost-effectiveness is presented as the incremental cost-effectiveness ratio (ICER). Costs were considered from the clinic perspective over a 1-year time horizon using real costs from the pilot trial. It was conservatively assumed there would be no costs savings. The Standard Gamble (SG) method was used to directly measure utilities. Results: Thirty-six participants met inclusion criteria for the present analyses. Mean age was 52 years; 61% were female and 86% were black. The total cost of STOMP was $483.83 per person. Using the SG method, the change in QALYs was 0.15, corresponding to an ICER of $3,225. Conclusions: STOMP’s cost/QALY is substantially lower than the $50,000 to $100,000/QALY benchmark often used to indicate cost-effectiveness. Although based on a pilot trial and, therefore, preliminary, these findings are promising, and suggest the importance of cost analyses in future STOMP trials.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalJournal of Medical Economics
DOIs
StateAccepted/In press - Sep 15 2017

Fingerprint

Chronic Pain
Cost-Benefit Analysis
HIV
Quality-Adjusted Life Years
Costs and Cost Analysis
Pain
Research Subjects
Benchmarking
Cost Savings
Pain Management
Self Care
Comorbidity
Research Design

Keywords

  • cost-effectiveness
  • HIV
  • pain
  • Self-management
  • utilities

ASJC Scopus subject areas

  • Health Policy

Cite this

Merlin, J. S., Westfall, A. O., Johnson, M. O., Kerns, R. D., Bair, M. J., Kertesz, S., ... Kilgore, M. (Accepted/In press). Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH). Journal of Medical Economics, 1-5. https://doi.org/10.1080/13696998.2017.1377719

Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH). / Merlin, Jessica S.; Westfall, Andrew O.; Johnson, Mallory O.; Kerns, Robert D.; Bair, Matthew J.; Kertesz, Stefan; Turan, Janet M.; Clay, Olivio J.; Starrels, Joanna L.; Kilgore, Meredith.

In: Journal of Medical Economics, 15.09.2017, p. 1-5.

Research output: Contribution to journalArticle

Merlin, JS, Westfall, AO, Johnson, MO, Kerns, RD, Bair, MJ, Kertesz, S, Turan, JM, Clay, OJ, Starrels, JL & Kilgore, M 2017, 'Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH)', Journal of Medical Economics, pp. 1-5. https://doi.org/10.1080/13696998.2017.1377719
Merlin, Jessica S. ; Westfall, Andrew O. ; Johnson, Mallory O. ; Kerns, Robert D. ; Bair, Matthew J. ; Kertesz, Stefan ; Turan, Janet M. ; Clay, Olivio J. ; Starrels, Joanna L. ; Kilgore, Meredith. / Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH). In: Journal of Medical Economics. 2017 ; pp. 1-5.
@article{e895861515d24c43a2984bbe72a8d38b,
title = "Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH)",
abstract = "Background: Chronic pain is a common, disabling, and costly comorbidity, particularly in people living with HIV (PLWH). This study developed and pilot tested a pain self-management intervention for chronic pain tailored to PLWH called Skills TO Manage Pain (STOMP). Objectives: Given the additional resources needed to deliver STOMP in HIV clinical settings, an important objective of the pilot study was to assess not only STOMP’s preliminary efficacy, but also its cost-effectiveness. Research design and subjects: The present study draws from a 44-participant, 2-arm randomized pilot trial of the STOMP intervention vs usual care among PLWH and at least moderate chronic pain (Clinicaltrials.gov: NCT02824562). Cost-effectiveness is presented as the incremental cost-effectiveness ratio (ICER). Costs were considered from the clinic perspective over a 1-year time horizon using real costs from the pilot trial. It was conservatively assumed there would be no costs savings. The Standard Gamble (SG) method was used to directly measure utilities. Results: Thirty-six participants met inclusion criteria for the present analyses. Mean age was 52 years; 61{\%} were female and 86{\%} were black. The total cost of STOMP was $483.83 per person. Using the SG method, the change in QALYs was 0.15, corresponding to an ICER of $3,225. Conclusions: STOMP’s cost/QALY is substantially lower than the $50,000 to $100,000/QALY benchmark often used to indicate cost-effectiveness. Although based on a pilot trial and, therefore, preliminary, these findings are promising, and suggest the importance of cost analyses in future STOMP trials.",
keywords = "cost-effectiveness, HIV, pain, Self-management, utilities",
author = "Merlin, {Jessica S.} and Westfall, {Andrew O.} and Johnson, {Mallory O.} and Kerns, {Robert D.} and Bair, {Matthew J.} and Stefan Kertesz and Turan, {Janet M.} and Clay, {Olivio J.} and Starrels, {Joanna L.} and Meredith Kilgore",
year = "2017",
month = "9",
day = "15",
doi = "10.1080/13696998.2017.1377719",
language = "English (US)",
pages = "1--5",
journal = "Journal of Medical Economics",
issn = "1369-6998",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Cost-effectiveness of a chronic pain intervention for people living with HIV (PLWH)

AU - Merlin, Jessica S.

AU - Westfall, Andrew O.

AU - Johnson, Mallory O.

AU - Kerns, Robert D.

AU - Bair, Matthew J.

AU - Kertesz, Stefan

AU - Turan, Janet M.

AU - Clay, Olivio J.

AU - Starrels, Joanna L.

AU - Kilgore, Meredith

PY - 2017/9/15

Y1 - 2017/9/15

N2 - Background: Chronic pain is a common, disabling, and costly comorbidity, particularly in people living with HIV (PLWH). This study developed and pilot tested a pain self-management intervention for chronic pain tailored to PLWH called Skills TO Manage Pain (STOMP). Objectives: Given the additional resources needed to deliver STOMP in HIV clinical settings, an important objective of the pilot study was to assess not only STOMP’s preliminary efficacy, but also its cost-effectiveness. Research design and subjects: The present study draws from a 44-participant, 2-arm randomized pilot trial of the STOMP intervention vs usual care among PLWH and at least moderate chronic pain (Clinicaltrials.gov: NCT02824562). Cost-effectiveness is presented as the incremental cost-effectiveness ratio (ICER). Costs were considered from the clinic perspective over a 1-year time horizon using real costs from the pilot trial. It was conservatively assumed there would be no costs savings. The Standard Gamble (SG) method was used to directly measure utilities. Results: Thirty-six participants met inclusion criteria for the present analyses. Mean age was 52 years; 61% were female and 86% were black. The total cost of STOMP was $483.83 per person. Using the SG method, the change in QALYs was 0.15, corresponding to an ICER of $3,225. Conclusions: STOMP’s cost/QALY is substantially lower than the $50,000 to $100,000/QALY benchmark often used to indicate cost-effectiveness. Although based on a pilot trial and, therefore, preliminary, these findings are promising, and suggest the importance of cost analyses in future STOMP trials.

AB - Background: Chronic pain is a common, disabling, and costly comorbidity, particularly in people living with HIV (PLWH). This study developed and pilot tested a pain self-management intervention for chronic pain tailored to PLWH called Skills TO Manage Pain (STOMP). Objectives: Given the additional resources needed to deliver STOMP in HIV clinical settings, an important objective of the pilot study was to assess not only STOMP’s preliminary efficacy, but also its cost-effectiveness. Research design and subjects: The present study draws from a 44-participant, 2-arm randomized pilot trial of the STOMP intervention vs usual care among PLWH and at least moderate chronic pain (Clinicaltrials.gov: NCT02824562). Cost-effectiveness is presented as the incremental cost-effectiveness ratio (ICER). Costs were considered from the clinic perspective over a 1-year time horizon using real costs from the pilot trial. It was conservatively assumed there would be no costs savings. The Standard Gamble (SG) method was used to directly measure utilities. Results: Thirty-six participants met inclusion criteria for the present analyses. Mean age was 52 years; 61% were female and 86% were black. The total cost of STOMP was $483.83 per person. Using the SG method, the change in QALYs was 0.15, corresponding to an ICER of $3,225. Conclusions: STOMP’s cost/QALY is substantially lower than the $50,000 to $100,000/QALY benchmark often used to indicate cost-effectiveness. Although based on a pilot trial and, therefore, preliminary, these findings are promising, and suggest the importance of cost analyses in future STOMP trials.

KW - cost-effectiveness

KW - HIV

KW - pain

KW - Self-management

KW - utilities

UR - http://www.scopus.com/inward/record.url?scp=85029604444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029604444&partnerID=8YFLogxK

U2 - 10.1080/13696998.2017.1377719

DO - 10.1080/13696998.2017.1377719

M3 - Article

C2 - 28880698

AN - SCOPUS:85029604444

SP - 1

EP - 5

JO - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

ER -